middle.news
Noxopharm Raises $2.5M to Kickstart HERACLES Trial and R&D Push
8:48am on Tuesday 20th of May, 2025 AEST
•
Biotechnology
Read Story
Noxopharm Raises $2.5M to Kickstart HERACLES Trial and R&D Push
8:48am on Tuesday 20th of May, 2025 AEST
Key Points
Raised $2.5 million through sale of Nyrada shares
Funds are non-dilutive, preserving shareholder equity
Capital earmarked for HERACLES clinical trial launch
Investment to continue in innovative R&D pipeline
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Noxopharm (ASX:NOX)
OPEN ARTICLE